Skip to content

Phentolamine mesylate in postmenopausal women with female sexual arousal disorder: a psychophysiological study.

by Eusebio Rubio-Aurioles, Marcela Lopez, Mirtha Lipezker, Claudia Lara, Abraham Ramírez, Claudia Rampazzo, María T Hurtado de Mendoza, Fred Lowrey, Lean a Loehr, Paul Lammers show all authors
Journal of sex & marital therapy ()
Get full text at journal


The objective of this study was to assess the potential of phentolamine as a treatment of postmenopausal women with female arousal disorder (FSAD). Vaginal photoplethismography and a subjective questionnaire were used. Forty one women were enrolled and four treatments were tested: vaginal solutions 5 mg and 40 mg and an oral tablet each of 40 mg of phentolamine and placebo. Physiological readings were significantly different from placebo in the women using hormone replacement therapy (HRT) with 40 mg of phentolamine in vaginal solution (p = 0.0186). Subjective reports also were significantly different from placebo with the vaginal solution 40 mg and the oral tablet of 40 mg of phentolamine among hormone replacement users. No significant differences were found among women not receiving HRT. Results indicate that phentolamine may show promise as treatment for FSAD in estrogenized postmenopausal women.

Cite this document (BETA)

Readership Statistics

8 Readers on Mendeley
by Discipline
50% Psychology
38% Medicine and Dentistry
13% Social Sciences
by Academic Status
50% Student > Ph. D. Student
25% Student > Doctoral Student
13% Researcher

Sign up today - FREE

Mendeley saves you time finding and organizing research. Learn more

  • All your research in one place
  • Add and import papers easily
  • Access it anywhere, anytime

Start using Mendeley in seconds!

Sign up & Download

Already have an account? Sign in